There were 909 press releases posted in the last 24 hours and 190,832 in the last 365 days.

Contact

Please use this form to send email to PR contact of this press release:
Veru Receives Positive Input from FDA on Phase 3 Pivotal Trial to Evaluate VERU-111 in Metastatic Castration Resistant Prostate Cancer

TO:



FROM:

Please check your email address!

Please, do not fill this field.

Please, do not change this field.

Please, do not fill if your javascript is turned off.

captcha image